These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10638209)

  • 21. Chylomicronemia syndrome.
    Chait A; Brunzell JD
    Adv Intern Med; 1992; 37():249-73. PubMed ID: 1557997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
    Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hyperchylomicronemia in two infants with novel APOC2 gene mutation.
    Kose E; Armagan C; Teke Kısa P; Onay H; Arslan N
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1289-1293. PubMed ID: 30307897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chylomicronemia].
    Yamamoto T; Kawakami M
    Nihon Rinsho; 1990 Nov; 48(11):2526-31. PubMed ID: 2270016
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein C-II Tuzla: a novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency.
    Okubo M; Toromanovic A; Ebara T; Murase T
    Clin Chim Acta; 2015 Jan; 438():148-53. PubMed ID: 25172036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.
    Evans D; Wendt D; Ahle S; Guerra A; Beisiegel U
    Hum Mutat; 1998; 12(3):217. PubMed ID: 10660334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Familial hyperchylomicronemia with a new mutation of the lipoprotein lipase gene].
    Causeret AS; Souillet AL; Marcais C; Prunetta V; Lachaux A; Faure M; Claudy A
    Ann Dermatol Venereol; 2001 Dec; 128(12):1343-5. PubMed ID: 11908140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The familial chylomicronemia syndrome.
    Santamarina-Fojo S
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):551-67, viii. PubMed ID: 9785052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutagenic aspects of the lipoprotein lipase gene].
    Petrescu-Dănilă E; Voicu PM; Ionescu CR
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):173-7. PubMed ID: 19292100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis].
    Sattler AM; Bock K; Schmidt S; Maisch B; Schaefer JR
    Z Kardiol; 2003; 92(Suppl 3):III64-7. PubMed ID: 14663605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipoprotein lipase deficiencies].
    Etienne J; Brault D
    Ann Biol Clin (Paris); 1992; 50(5):299-309. PubMed ID: 1485686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting APOC3 in the familial chylomicronemia syndrome.
    Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL
    N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for genetic lipoprotein lipase deficiency: from promise to practice.
    Nierman MC; Rip J; Twisk J; Meulenberg JJ; Kastelein JJ; Stroes ES; Kuivenhoven JA
    Neth J Med; 2005 Jan; 63(1):14-9. PubMed ID: 15719847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects.
    Santamarina-Fojo S; Brewer HB
    JAMA; 1991 Feb; 265(7):904-8. PubMed ID: 1992190
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).
    Haubenwallner S; Hörl G; Shachter NS; Presta E; Fried SK; Höfler G; Kostner GM; Breslow JL; Zechner R
    Genomics; 1993 Nov; 18(2):392-6. PubMed ID: 8288243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.
    Kawashiri MA; Higashikata T; Mizuno M; Takata M; Katsuda S; Miwa K; Nozue T; Nohara A; Inazu A; Kobayashi J; Koizumi J; Mabuchi H
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6541-4. PubMed ID: 16174715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roundtable on etiology of familial chylomicronemia syndrome.
    Brown WV; Gaudet D; Goldberg I; Hegele R
    J Clin Lipidol; 2018; 12(1):5-11. PubMed ID: 29452917
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment.
    Gallo A; Béliard S; D'Erasmo L; Bruckert E
    Curr Atheroscler Rep; 2020 Aug; 22(11):63. PubMed ID: 32852651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation.
    Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G
    J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.